CarbonScape to Provide Renewable Feedstock to Support Industrial Biographite Production

These agreements, with some of the largest forestry companies in the world, follow CarbonScape's recent announcement of plans to build a demonstration facility in Kotka, Finland, after having operated their pilot plant facility in New Zealand and producing biographite over the past six years.

The agreements outline the terms for CarbonScape’s suppliers to provide a secure, long-term supply of sustainably sourced woodchip, the feedstock in CarbonScape's innovative biographite production process, sufficient to cover full industrial production capacity for at least 10 years.

Biographite, a sustainable alternative to traditional graphite, is produced using woodchip side streams from the renewable forestry and timber industry, offering a low-cost, locally produced, high-performance anode material for the rapidly growing lithium-ion battery market.

CarbonScape plans to begin constructing its first industrial plant in 2027. By utilizing renewable feedstock secured from its upstream partners as part of these agreements, the organization aims to start producing biographite for supply to commercial customers in early 2029.

Vincent Ledoux Pedailles, CCO of CarbonScape, commented, "These supply agreements with our upstream partners are another significant milestone as we progress towards the construction of our industrial scale plants. 

"Securing a reliable, sustainable supply of woodchip is crucial to our future operations. Together with our partners, we're advancing the commercialization of biographite and redefining what's possible in the global battery industry."

With global demand for graphite in EV batteries projected to soar and China currently dominating over 95% of graphite production, commercial biographite production represents an innovation advantage and significant step towards diversifying and localizing critical mineral supply chains.

Projects progressing on several fronts

• Pilot plant and Lab (New Zealand): biographite anode sample production, cell manufacturing and testing continuing.
• Demonstration plant (Finland): FEL3 Engineering study finalized, EPCM selection in finalization.
• Product qualification: ongoing product validation with leading cell makers and OEMs in Asia, Europe and North America. Tier 1 product specifications achieved.
• Engineering: Class 4 study finalized at the end of 2024 confirming low manufacturing cost position, further engineering being carried out as well as toll manufacturing and vendors testing to mitigate scale up risk.
• Capital raise: supported by Morgan Stanley, the process continues with a number of strategic and financial investors having submitted their interest to participate in the round.
• Public funding: applications both submitted or being drafted for public funding in Europe and in the US.